Degenerative diseases of the bone and joint
Conditions
Interventions
Intervention group:Golden Tenge Capsules
Control group:Diclofenac sodium extended-release tablets
Sponsors
Gansu Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria for KOA (unilateral or bilateral). 2. Patients in the age group of 50 to 70 years, male or female. 3. The patient's knee X-ray K-L classification falls into grades II to III. 4. The patient's KOA stage is in remission or recovery. 5. patient's KOA duration is = 6 months. 6. VAS score of 3~7. 7. Signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who have taken Chinese herbal soup, proprietary Chinese medicine or other western medicine for the treatment of osteoarthritis of the knee within the last two weeks. 2. Patients with combined osteoarthritic tumours of the knee, tuberculosis or rheumatoid arthritis, gouty arthritis, etc. 3. Patients who have had knee replacement surgery. 4. Patients with severe mental disorders and mental retardation, etc. who are unable to complete the questionnaire. 5. Patients with a combination of serious cardiovascular, respiratory, digestive, immune, endocrine and haematological disorders, as well as liver and kidney insufficiency, metabolic diseases and malignant tumours. 6. Those who are participating in several clinical subjects at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| WOMAC score;Clinical efficacy assessment; | — |
Countries
China
Contacts
Public ContactShenghua Li
Gansu Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed